Transaction Follows Completion of Comprehensive Strategic Review by Special Committee of the Board to Maximize Shareholder Value Farmingdale, NY -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced that on June 23, 2025, following the market close, it entered into an Agreement and Plan of Merger (the “Merger Agreement”) to be acquired [...]

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference standards with its analytical solutions, including the Maurice system, to support monoclonal antibody and gene therapy development around the world. More than 160 antibody [...]

Lausanne, Switzerland and Frederick, MD – Alithea Genomics, a pioneering biotech company based in Switzerland and the USA specializing in high-throughput RNA sequencing solutions, today announced the commercial launch of MERCURIUS™ FLASH-seq, a next-generation library preparation kit for full-length single-cell RNA sequencing. MERCURIUS™ FLASH-seq is based on the method first published in Nature Biotechnology. Alithea Genomics significantly [...]

BRANFORD, Conn. -- Jun. 24, 2025-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the placement of its Platinum® Pro instrument at the Broad Institute. This collaboration aims to support scientific innovation across oncology, therapeutics, and other key areas of biomedical research. This placement expands [...]

For powering next-generation regenerative medicine research Meet our hiEX™ Research iPSC Exosomes, a new research-use-only product designed to enable scientists to explore the therapeutic potential of iPSC-derived exosomes in areas such as wound healing, aging, and nerve regeneration Isolated from a single, well-characterized induced pluripotent stem cell (iPSC) line, hiEX™ Research iPSC Exosomes offer a consistent and [...]

Santa Clara, CA – Picarro Inc., a global leader in methane emission management and reduction solutions, and GTI Energy, a technology development and training organization, today announced the extension of their partnership on GTI Energy’s Veritas Initiative. The companies will continue to collaborate to further develop, validate, and implement Veritas’ technical protocols for reducing methane [...]

Simoa Technology Advances Earlier Disease Detection by Measuring Signature Biomarkers BILLERICA, MA – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration by the Ministry of Food and Drug Safety (MFDS) in South Korea through its regional distribution [...]

Cambridge, UK – SPT Labtech, a global leader in life sciences automation solutions, today announced its inclusion in an Illumina partnership program to develop Illumina Qualified automated library prep methods, following the successful development and qualification of an automated workflow for the Illumina DNA Prep library preparation kit on its innovative firefly® liquid handling platform. The partnership reflects a growing demand for [...]

The opening of a new, modern office enables greater agility, team collaboration, and closer connectivity with the Philippine market. A research grant judging session was also held during the inaugural event, reaffirming Esco’s commitment to supporting the scientific community in the Philippines. PHILIPPINES – Esco Lifesciences Group is proud to announce the opening of its new [...]

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies Operating Structure and Enables Achievement of Adjusted EBITDA Break-Even Cash & Cash Equivalents of At Least $550 Million Expected at Close [...]